United States· US:69945-096_47bb627f-3944-5901-e063-6294a90a38cb

Technescan MAG3

A betiatide product containing betiatide, registered in United States by Curium US LLC. The same ATC class is registered in 3 of our 19 countries.

ATC BetiatideUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTechnescan MAG3ATCBetiatideREGISTER NO.US:69945-096_47bb627f…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Betiatide is registered in 3 of 19 countries.

Countries holding a registration under ATC Betiatide (betiatide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 1 of them publish a price we can compare per daily dose

Betiatide · ATC Betiatide

3 / 19 countries

  • Germany
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
BETIATIDE
Manufacturer
Curium US LLC
Country
United States (US)
ATC code
Betiatide
ATC class
Betiatide
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    6994509620
    5 VIAL in 1 CELLO PACK (69945-096-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
  • ndc11
    69945-096-20

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Betiatide in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All betiatide products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Renoscint Mag3, Technescan Mag3
  • Belgium · Technescan Mag3
  • Czechia · Renoscint Mag3, Technescan Mag3
  • Germany · Renoscint Mag3, Technescan Mag3
  • Denmark · Renoscint Mag3, Technescan Mag3
  • Spain · Mag3 Radiopharmacy, Mag3 Technescan
  • Finland · Technescan Mag3
  • France · Technescan Mag 3
  • United Kingdom (Northern Ireland) · Renoscan Mag3, Technescan Mag3
  • Greece · Technescan Mag3
  • Hungary · Renoscint Mag3, Technescan Mag3
  • Ireland · Technescan Mag3
  • Italy · Medirenoscint, Technescan Mag3
  • Malta · Renoscint Mag3
  • Netherlands · Technescan Mag3
  • Norway · Technescan Mag3
  • Poland · Renoscint Mag3
  • Portugal · Technescan Mag3
  • Sweden · Technescan Mag3
  • Slovakia · Technescan Mag3

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cafd6738-0b16-4611-8b75-beb1d1c7f32c
GET /v1/drugs/cafd6738-0b16-4611-8b75-beb1d1c7f32c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "1",
  "substance": "BETIATIDE",
  "productndc": "69945-096",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA019882",
  "marketing_category": "NDA"
}

See everything about betiatide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.